Indian Pharmaceutical Industry has The Twin Engines of Growth
Domestic Growth: To touch US $57 billion in 2030 growing @ 10% -12%1
Export Surge: To touch US $44 billion in 2030 growing @ 8% - 10%2
Factors fuelling the engines:
Domestic Growth Drivers
Rising in Life Expectancy3
US $200 bn is expected to be spent on Medical Infrastructure by 2024 4
Increasing Health Insurance Penetration
Rising Private & Government Healthcare Spending.
Introduction of “Ayushman Bharat”, the largest Healthcare scheme in the world5
Export Growth Drivers
Pharmergence - Emerging countries accounts for 24% of Global Pharma Market6
India - largest producer of the Generic Medicines Globally
Over 80% of world’s Antiretroviral (AIDS) Drugs supplied by India7
Approx. 40% lower cost of production in India vis-a-vis China and Eastern Europe8
India on its way to become the World’s one-stop-shop for Contract research and manufacturing services (CRAMS)9
Changing facet of Healthcare in India
Emergence of Private Hospitals as Mass Caregivers.10
Rapid expansion & consolidation of Diagnostics Market.
Rising customization & at-home provision of Diagnostics & Disease Management
Emergence of Health-tech Start-ups
Rising trend of Wellness, Good living & Grooming increasing the demand for Therapeutic, Cosmeceutical & Derma products
Two-pronged transformation of Healthcare landscape by integrating the Pharma ‘Manufacturing’ and ‘Healthcare Services’ in India.
Welcome to the New Dawn of Pharma & Healthcare Industry.
Aditya Birla Sun Life Pharma & Healthcare Fund - An open-ended equity scheme investing in Pharma and Healthcare Services Sector Click here to know more
Mutual Fund investments are subject to market risks, read all scheme related documents carefully.